Tempus (IPO)
Funding Details
Awarder
Inbox
Date Award
June 14, 2024
Vertical
Genomic testing and data analysis
Valuation
$6,000,000
Funding Amount
$411,000,000
Company Info
Founding Year
2015
Traction
Tempus had revenues of $531 million in 2023 with a net loss of $290 million. The company's operating losses have decreased from 83% in 2022 to 37% in 2023.
Revenue Amount
$531,000,000
Organizations Involved
NEA, Revolution, T. Rowe Price, SoftBank
Founders
Eric Lefkofsky
Market
Health tech
Location
US
Coinvestors
NEA, Revolution, T. Rowe Price, SoftBank
Company Description

Tempus is a genomic testing and data analysis company founded by Eric Lefkofsky, who previously founded Groupon. The company aims to leverage technology and data derived from genomic sequencing to improve healthcare.

Links